Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

Two hands shaking symbolising partnership

Key barriers to effective patient engagement in pharma, and how to fix them: Making engagement processes more patient friendly

In the first of this blog series, Patient Engagement Lead, Philippa Pristerà looks at making engagement processes more patient friendly

Cuttsy + Cuttsy

- PMLiVE

NICE recommends Novartis’ Adakveo for sickle cell disease

The treatment for sickle cell disease is the first in more than 20 years

- PMLiVE

Andy Black joins Lucid Group as non-executive chairman

Black is co-founder of Kinapse and a Professor of Practice at King’s College London

- PMLiVE

AstraZeneca requests Emergency Use Authorization from FDA for COVID-19 antibody

Phase 3 data shows the long-acting antibody combination produces a 77% reduction in the risk of developing symptomatic COVID-19

- PMLiVE

Christianna Gorin is appointed Health Practice Lead and Chief Strategy Officer, VMLY&R Health

With origins in health consultancy and insight, Gorin has spent over 20 years in healthcare

- PMLiVE

Fishawack Health appoints new CEO, Jonathan Koch

Koch will draw on his exceptional experience leading global, customer-centered organizations of scale to build a sustainable future for Fishawack Health.

Avalere Health

- PMLiVE

Janssen’s RSV vaccine provides high protection against respiratory infections

The phase 2b data showed the RSV vaccine provided 80% protection against lower respiratory infections in adults aged 65 and older

- PMLiVE

Black community representation in clinical trials

This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community.

Innovative Trials

ASHFIELD HEALTH LAUNCHES HEALTH INTELLIGENCE PLATFORM, GRAVITY.AI

Dynamic data-driven solution unlocks deeper insights and powers stronger omnichannel experiences.

Inizio

Day in a #LucidLife – Meet Nick

Nick discusses his career journey with Lucid Group and describes what a typical day at Lucid looks like for him.

Lucid Group Communications Limited

- PMLiVE

Merck and Ridgeback’s oral antiviral halves COVID-19 risk of hospitalisation or death

The phase 3 study shows the risk was halved compared to placebo for patients with mild or moderate COVID-19

- PMLiVE

FDA grants Enhertu Breakthrough Therapy Designation in breast cancer

Phase 3 trial data presented at ESMO shows Enhertu significantly reduced the risk of disease progression or death

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links